Clinical trials
Completed Papillomavirus Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 8 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 13 |
| AIDS Malignancy Consortium | 6 |
| National Cancer Institute (NCI) | 5 |
| University of Washington | 5 |
| Gen-Probe, Incorporated | 4 |
| Jonsson Comprehensive Cancer Center | 2 |
| Mayo Clinic | 2 |
| OHSU Knight Cancer Institute | 2 |
| Ohio State University Comprehensive Cancer Center | 2 |
| University of Alabama at Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Papillomavirus Infections | 81 |
| Uterine Cervical Neoplasms | 30 |
| Precancerous Conditions | 9 |
| Anus Neoplasms | 8 |
| HIV Infections | 8 |
| Squamous Intraepithelial Lesions | 6 |
| Uterine Cervical Dysplasia | 6 |
| Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Virus Diseases | 5 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.